12/02/2024 - Outreach, Projects, Research

VIDEO: Life Cycle of 'Plasmodium vivax': Highlighting New Cryptic Erythrocytic Stages

To better understand the complexity of P. vivax infections, the CaixaResearch project "Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria" has produced this video to disseminate key insights into cryptic erythrocytic infections. The initiative is led by Hernando A del Portillo and Carmen Fernandez-Becerra, group leaders of the Plasmodium vivax and Exosome Research Group (PvREX) at the Barcelona Institute for Global Health (ISGlobal) and the Germans Trias i Pujol Research Institute (IGTP) in Spain.

02/02/2024 - Projects, Research

COVID-19 vaccination in people with HIV, a pending issue

Two studies by CEEISCAT with the PISCIS cohort show that people living with HIV have been less vaccinated with the full initial regimen against COVID-19

29/01/2024 - Projects, Research, Success Stories

The European Union launches the THRIVE project to improve the prognosis of children and adults with liver cancer

The European Union's project THRIVE held its kick-off meeting on 12 January 2024 in Barcelona. The project is coordinated by Josep M. Llovet (IDIBAPS). IGTP collaborates as a partner through c-LOG, led by Carolina Armengol.

23/01/2024 - Projects, Research

Artificial intelligence as key to predicting the risk of type 2 diabetes

Research teams from BSC-CNS, UPV/EHU and IGTP are working on a project that uses artificial intelligence to predict and prevent type 2 diabetes. This initiative is part of the Complementary Plan for Biotechnology Applied to Health, coordinated by IBEC.

18/01/2024 - Projects

Four IGTP projects financed with 1.7 million euros by the Spanish Ministry of Science and Innovation

The Germans Trias i Pujol Research Institute (IGTP) has received funding to develop four projects as part of the "Public-Private Collaboration Projects" call by the State Research Agency of the Ministry of Science and Innovation, amounting to a total of €1,706,019.92.

18/01/2024 - Projects, Research, Success Stories

European scientists unite in the quest for breakthroughs in immunotherapy treatments

The network IMMUNO-model has brought together researchers and innovators from all over the world to foster research in immuno-oncology through the advancement in the development and implementation of pre-clinical models. This initiative is funded by the European Cooperation in Science and Technology (COST) programme.

15/01/2024 - Projects, Research, Success Stories

CEEISCAT shares the results of the TÉSTATE project on HIV and hepatitis C

Two studies by CEEISCAT-IGTP have evaluated an online HIV and HCV self-testing strategy, demonstrating that it is effective and safe.

11/01/2024 - Campus Can Ruti, Innovation, Projects

The Innomed programme is launched to boost health innovation

Institutions in and around the Can Ruti Campus have come together to develop Innomed, a programme aimed at sharing skills, knowledge, and resources to boost innovation. The initiative has recently received support from the ITEMAS platform.

12/12/2023 - Campus Can Ruti, Conferences, Projects, Success Stories

The Talents programme awards grants to research projects from around twenty health professionals affiliated with Germans Trias

Fundació Catalunya La Pedrera provides these awards, supporting and enhancing the careers of young talents with both its own resources and contributions from the ICS Gerència Territorial Metropolitana Nord.

09/11/2023 - Institutional, Projects, Research

GCAT takes part in one of the projects funded by Fundació La Marató de 3Cat

The funds raised in the 2022 edition of La Marató de 3Cat will enable 71 research teams to conduct 37 projects in cardiovascular health to advance in the prevention, diagnosis, and treatment of diseases that represent the leading cause of death in developed countries. One of the awarded projects involves the participation of researchers from the GCAT of the IGTP, and is coordinated by Dr Camille Lassale from ISGlobal.